ATC Group: C07FX06 Carvedilol and ivabradine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C07FX06 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C07 Beta blocking agents
3 C07F Beta blocking agents and other antihypertensives
4 C07FX Beta blocking agents, other combinations
5 C07FX06

Active ingredients in C07FX06

Active Ingredient Description
Carvedilol and Ivabradine

Carvedilol is a vasodilating non-selective beta-blocker, which reduces the peripheral vascular resistance by selective alpha 1-receptor blockade and suppresses the renin-angiotensin system through non-selective betablockade. Ivabradine is a pure heart rate lowering agent, acting by selective and specific inhibition of the cardiac pacemaker If current that controls the spontaneous diastolic depolarisation in the sinus node and regulates heart rate. The cardiac effects are specific to the sinus node with no effect on intra-atrial, atrioventricular or intraventricular conduction times, nor on myocardial contractility or ventricular repolarisation.

Related product monographs

Title Information Source Document Type  
CARIVALAN Film-coated tablet Health Sciences Authority (SG) MPI, EU: SmPC

Medicines in this ATC group

Cyprus (CY)

France (FR)

Lithuania (LT)

Poland (PL)

Romania (RO)

Singapore (SG)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.